Skip to main content
Acticor Biotech logo

Acticor Biotech — Investor Relations & Filings

Ticker · ALACT ISIN · FR0012519668 LEI · 969500K433EK1G89EV95 PA Manufacturing
Open in API
Filings indexed 200 across all filing types
Latest filing 2023-08-04 Declaration of Voting R…
Country FR France
Listing PA ALACT

About Acticor Biotech

https://www.acticor-biotech.com

Acticor Biotech is a clinical-stage biopharmaceutical company that originated as a spin-off from the French National Institute of Health and Medical Research (INSERM). The company is dedicated to developing innovative treatments for thrombotic diseases, with a primary focus on the acute phase of ischemic stroke. Its lead drug candidate, glenzocimab, is a humanized monoclonal antibody fragment designed to target platelet glycoprotein VI (GPVI), a key receptor involved in thrombosis. The therapeutic approach aims to provide an effective anti-thrombotic effect to safely manage stroke patients without increasing the risk of bleeding, a significant complication associated with existing treatments.

Recent filings

Filing Released Lang Actions
Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "Disclosure of the total number of voting rights and shares as of July 31, 2023" and provides a table detailing the number of shares and voting rights as required by French Commercial Code and AMF regulations. This type of mandatory periodic disclosure regarding the company's capital structure and voting power is typically classified as a regulatory filing or a specific announcement related to share capital/voting rights. Since the provided list includes 'Declaration of Voting Results & Voting Rights Announcements' (DVA) and 'Share Issue/Capital Change' (SHA), I must choose the most appropriate one. This document specifically reports the total number of voting rights, which is a key component of shareholder structure reporting, often linked to general meetings or regulatory compliance regarding ownership thresholds. Given the explicit focus on the 'total number of voting rights and shares' as of a specific date, it aligns closely with regulatory reporting on capital structure, but it is not a declaration of *results* from a vote (DVA) nor an announcement of a *change* like a split or new issue (SHA). It is a routine disclosure of the current state of capital/voting rights. In many contexts, this falls under general regulatory reporting. However, looking at the options, it is a specific disclosure about the capital base. Since it is a mandatory disclosure related to the capital structure and voting rights, and it is not a general earnings release or a proxy statement, it fits best under a general regulatory filing or a specific capital announcement. Since it is a routine disclosure of the current share count and voting rights, and not a transaction (POS) or a change in structure (SHA), and it is not a declaration of *results* (DVA), the most fitting general category for mandatory, non-financial periodic disclosures that don't fit elsewhere is often RNS, but DVA is about voting results. Because this is a disclosure of the *total number* of rights, which is a prerequisite for shareholder meetings, and it is a specific regulatory requirement, I will check if it fits DVA or RNS. DVA is for *results* of votes. This is a statement of the *basis* for voting. Given the options, and the nature of mandatory periodic disclosure of share capital status, it is a specific regulatory filing. If a more specific category existed for 'Share Capital Status Report', that would be ideal. Lacking that, and noting it is a formal 'COMMUNIQUE DE PRESSE' disclosing regulatory data, RNS (Regulatory Filings) is the safest fallback, but let's re-evaluate DVA. DVA is for 'Official results from shareholder votes'. This is not results, but the denominator. Therefore, RNS is the most appropriate catch-all for this specific, non-financial, regulatory status update. However, if we consider the closest fit among the specific options, it relates to the mechanics of voting rights. Given the ambiguity, and the fact that it is a formal press release disclosing required regulatory data, RNS is the standard fallback. I will assign a high confidence score as it is clearly a regulatory disclosure of share count.
2023-08-04 English
Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social au 31 juillet 2023" (Monthly information relating to the total number of voting rights and shares comprising the share capital as of July 31, 2023). It explicitly references Article 223-16 of the AMF General Regulation and provides a table detailing the total number of shares and voting rights as of a specific date (31/07/2023). This content directly relates to the calculation and disclosure of share capital structure and voting rights, which is a specific type of regulatory disclosure. While it is a press release, its core subject matter aligns most closely with disclosures related to share capital changes or major shareholding notifications, but given the specific nature of reporting total voting rights and shares, it is a common component of regulatory filings. However, none of the provided codes perfectly match a 'Total Voting Rights Disclosure'. Comparing the options: It is not an ER (Earnings Release), 10-K (Annual Report), or IR (Interim Report). It is not a DIRS (Director's Dealing) or MRQ (Major Shareholding Notification) in the typical sense, although it relates to share structure. The closest fit among the provided options that deals with share structure and ownership reporting, especially when a specific code for 'Total Voting Rights' is missing, is often categorized under general share/capital announcements. Since it reports the total number of shares and voting rights, it is a fundamental disclosure about the company's capital structure. Option 'SHA' (Share Issue/Capital Change) is plausible, but this is a periodic update, not necessarily an 'issue' or 'change' announcement. Option 'MRQ' (Major Shareholding Notification) is for changes crossing thresholds. Given the context of mandatory periodic disclosure of total shares/voting rights under French regulation (AMF), and lacking a specific code, this type of filing often falls under general regulatory announcements or capital structure updates. Since it is a formal, periodic disclosure mandated by regulation, and it details the composition of the capital, 'SHA' (Share Issue/Capital Change) is the most relevant category dealing with the share base, even if it's a reporting update rather than an active change event. However, if we strictly adhere to the definitions, this is a disclosure of the capital base, which is a prerequisite for many other filings. Given the options, and recognizing this is a mandatory disclosure about the share base, 'SHA' is the best fit among the specific codes, although 'RNS' (Regulatory Filings) is a strong fallback. I will classify it as 'SHA' as it directly concerns the total share capital count, which is the basis for capital changes.
2023-08-04 French
Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "Disclosure of the total number of voting rights and shares as of June 30, 2023" and explicitly states it is disclosed pursuant to Article L. 233-8 II of the French Commercial Code and Article 223-16 of the General Regulation of the French Financial Markets Authority (AMF). It provides a table detailing the number of shares and voting rights as of a specific date. This type of mandatory disclosure regarding the capital structure and voting rights is a specific regulatory filing. Among the provided codes, 'Declaration of Voting Results & Voting Rights Announcements' (DVA) is the most appropriate fit for a formal disclosure of the total number of voting rights and shares, as this information is crucial for determining voting power ahead of any general meeting or for regulatory compliance regarding ownership structure.
2023-07-07 English
Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social au 30 juin 2023" (Monthly information relating to the total number of voting rights and shares comprising the share capital as of June 30, 2023). It explicitly references Article 223-16 of the AMF General Regulation, which mandates the disclosure of the total number of shares and voting rights. This type of periodic disclosure regarding the total number of shares and voting rights is a specific regulatory requirement, often related to capital structure changes or general compliance updates. While it involves share counts, it is not a formal share issue announcement (SHA) or a transaction in own shares (POS). It is a mandatory regulatory disclosure concerning the capital structure as of a specific date. Among the provided codes, this specific type of monthly capital/voting rights disclosure is best categorized as a general Regulatory Filing (RNS) or, given its focus on capital structure components, potentially a Share Issue/Capital Change (SHA) if it were announcing a change, but since it's a routine monthly update on the total count, RNS is a strong candidate. However, since the content is strictly about the total number of shares and voting rights, which is a fundamental aspect of capital structure reporting, and it is a formal press release format, it aligns closely with mandatory regulatory reporting that isn't covered by the other specific codes. Given the options, and recognizing this is a mandatory disclosure about the capital base, it is closest to a general regulatory announcement (RNS) or a specific capital structure notification. Since there is no specific code for 'Total Voting Rights Disclosure', RNS (Regulatory Filings) serves as the most appropriate fallback for mandatory, non-financial periodic regulatory updates.
2023-07-07 French
Acquisition or disposal of the issuer's own shares / Information relating to the liquidity contract
Regulatory Filings Classification · 99% confidence The document is explicitly titled "HALF-YEAR REPORT ON THE LIQUIDITY CONTRACT WITH THE BROKERAGE FIRM KEPLER CHEUVREUX". It provides detailed financial and transactional data comparing the period ending June 30, 2023, against the previous period ending December 31, 2022. This structure—a comprehensive report covering a six-month period (half-year) with detailed financial metrics—aligns perfectly with the definition of an Interim / Quarterly Report (IR). Although it focuses on a liquidity contract, the nature of the document is a periodic financial disclosure for the first half of the year, not just a brief announcement of a report's publication (RPA) or a general regulatory filing (RNS).
2023-07-07 English
Acquisition ou cession des actions de l'émetteur / Information relative au contrat de liquidité
Capital/Financing Update Classification · 95% confidence The document is titled "BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITÉ CONTRACTÉ AVEC LA SOCIÉTÉ DE BOURSE KEPLER CHEUVREUX" (Semi-annual statement of the liquidity contract entered into with the brokerage firm Kepler Cheuvreux). It details the status of a liquidity contract as of June 30, 2023, comparing it to the previous statement (December 31, 2022) and the initial setup. This type of disclosure, often mandated by regulatory bodies like the AMF (mentioned in the text), relates to the management of the company's own shares or market stabilization activities, which falls under share transactions or capital structure management. Since the document specifically reports on the activity of a liquidity contract (which involves buying and selling shares to maintain market stability), it aligns most closely with the 'Transaction in Own Shares' category (POS), which covers share repurchase/issuance activities, or potentially Capital/Financing Update (CAP) or Regulatory Filings (RNS). Given the specific focus on the liquidity contract activity (buying/selling shares on the market), POS is the most precise fit among the provided options, as liquidity contracts are mechanisms for managing share supply/demand, often involving treasury shares or market operations. It is not an Annual Report (10-K), Interim Report (IR), Earnings Release (ER), or a general announcement of a report (RPA/RNS), but a specific periodic report on a financing/trading mechanism.
2023-07-07 French

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.